European Journal of Rheumatology
Case Report

A case of central nervous system nocardiosis in a patient with lupus treated with belimumab

1.

Department of Rheumatology, Medstar Washington Hospital Center, Washington, USA

2.

Department of Rheumatology, Medstar Washington Hospital Center, Washington, USA; Department of Clinical Medicine, Georgetown University Medical Center, Washington, USA

Eur J Rheumatol 2016; 3: 188-190
DOI: 10.5152/eurjrheum.2016.15083
Read: 1979 Downloads: 1117 Published: 03 September 2019

Abstract

Belimumab was approved by the United States Food and Drug Administration in March 2011 as the first biological agent for treating active systemic lupus erythematosus (SLE). To the best of our knowledge, this is the first case report regarding a patient with SLE treated with belimumab who was diagnosed with central nervous system nocardiosis.Belimumab was approved by the United States Food and Drug Administration in March 2011 as the first biological agent for treating active systemic lupus erythematosus (SLE). To the best of our knowledge, this is the first case report regarding a patient with SLE treated with belimumab who was diagnosed with central nervous system nocardiosis.

Files
EISSN 2148-4279